As President Donald Trump touts new deals to cut the cost of blockbuster drugs like Wegovy and Zepbound, he’s barely ...

Medicare will cover weight-loss drugs under a deal between the Trump administration and drugmakers Eli Lilly and Novo Nordisk ...

Medicare will cover semaglutide (Wegovy) and tirzepatide (Zepbound) for their weight management indications for people with ...

The Danish pharmaceutical giant Novo Nordisk has struck an agreement with the Centers for Medicare & Medicaid Services (CMS) ...

Seniors could soon pay just $50 a month for Ozempic and other drugs used for weight loss under a new Trump plan to cut prescription costs.

Agreements with Eli Lilly and Novo Nordisk firms will lower costs to as little as $149 per month and align Medicaid prices ...

Novo Nordisk and Eli Lilly reached deals to lower GLP-1 drug costs for Medicare and Medicaid patients under Trump’s new ...

As part of the Inflation Reduction Act, manufacturers are required to pay a rebate to Medicare if a drug's price increase exceeds the rate of inflation. CMS said it intends to send the first invoices ...

The list prices of obesity drugs Wegovy and Zepbound are over $1,000, but that’s not necessarily what you pay.

President Donald Trump has long pushed to cut the price of GLP-1 medications, often expressing frustration about the high ...

Fall enrollment is on. Some plans are raising premiums for Part D, which covers prescriptions, by $50 or more per month, while others are lowering them.

Learn about the biggest Medicare changes coming in 2026, from rising premiums to new drug caps and coverage rules, so you can ...